NFKB1 and liver cancer: Previous researches have reported that LCN2 could be transcriptionally upregulated by NF-κB in liver cancer cells and that, in NB4 cells,27 membrane WTX is capable of interacting with β-arrestin2, which has been recognized to be a negative regulator of the NF-κB pathway.28